Lupin unveils generic equivalent of Revatio for Oral Suspension in US Ruchika Sharma30 Sept 2022 3:30 PM ISTThe medication is used to treat erectile dysfunction and pulmonary arterial hypertension.
Lupin bags USFDA approval for Mirabegron ER tablets to treat overactive bladder Ruchika Sharma30 Sept 2022 11:28 AM ISTThe product will be manufactured at Lupin's facility in Nagpur, India.
USFDA inspection: Lupin gets warning letter for Tarapur facility Ruchika Sharma29 Sept 2022 2:30 PM ISTMumbai: Pharma major, Lupin, has announced that the Company has received a warning letter from the US Food and Drug Administration (USFDA)...
Lupin bags USFDA nod for Diclofenac Sodium Topical Solution to treat arthritic knee pain Ruchika Sharma23 Sept 2022 11:15 AM ISTThe product will be manufactured at Lupin's facility in Pithampur, India.
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sept 2022 2:19 PM ISTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Lupin unveils Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in US Ruchika Sharma9 Sept 2022 12:27 PM ISTThe product is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
Lupin, DKSH ink pact to commercialize 5 of Alvotech proposed biosimilars in Philippines Ruchika Sharma7 Sept 2022 11:45 AM ISTThis agreement enhances Multicare's oncology, rheumatology, gastroenterology, and ophthalmology, portfolio, which currently consists of three...
Lupin, Zydus Lifesciences recall products in US over manufacturing issues Ruchika Sharma3 Sept 2022 12:03 PM ISTNew Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...
Lupin Gets USFDA Nod For Generic Cancer Treatment Drug Kajal Rajput30 Aug 2022 1:29 PM ISTMumbai: Global pharma major Lupin Limited (Lupin) in partnership with Pharmascience Inc. today announced that it has received tentative approval from...
Lupin rolls out Desvenlafaxine ER tablets in US Ruchika Sharma27 Aug 2022 9:30 AM ISTMumbai: Global pharma major, Lupin Limited, has announced the launch of Desvenlafaxine Extended-Release Tablets, 25 mg, having received an approval...
Lupin to acquire diabetes brands Ondero, Ondero-Met from Boehringer Ingelheim for Rs 207 crore Ruchika Sharma25 Aug 2022 3:30 PM ISTNew Delhi: Lupin Limited is soon going to acquire two diabetes brands Ondero and Ondero - Met from Boehringer Ingelheim International GmbH for Rs...
Lupin, I'rom ink pact for biosimilar Denosumab Ruchika Sharma25 Aug 2022 12:30 PM ISTCurrently, Denosumab is available under two brands, Pralia and Ranmark.
